Search Results - Urbaityte, Rimgaile
- Showing 1 - 8 results of 8
-
1
Abacavir Use and Risk for Myocardial Infarction and Coronary Artery Disease: Updated Meta-analysis of Data from Clinical Trials by Nan, Cassandra, Shaefer, Mark S, Urbaityte, Rimgaile, Oyee, James, Hopking, Judy, Ragone, Leigh, McCoig, Cynthia, Vannappagari, Vani
Published 2017Text -
2
A retrospective clinical audit of general practices in Australia to determine the motivation for switch to dolutegravir/abacavir/lamivudine and clinical outcomes by Ferrer, Pedro E, Bloch, Mark, Roth, Norman, Finlayson, Robert, Baker, David, Koh, Ken, Orth, David, Urbaityte, Rimgaile, Brown, Dannae, Drummond, Fraser
Published 2017Text -
3
Abacavir Use and Risk for Myocardial Infarction and Cardiovascular Events: Pooled Analysis of Data From Clinical Trials by Nan, Cassandra, Shaefer, Mark, Urbaityte, Rimgaile, Oyee, James, Hopking, Judy, Ragone, Leigh, Perger, Teodora, Win, Beta, Vangerow, Harald, McCoig, Cynthia, Vannappagari, Vani
Published 2018Text -
4
2842. Durable Efficacy of Two-Drug Regimen (2DR) of Dolutegravir (DTG) plus Lamivudine (3TC) in Antiretroviral Treatment-Naïve Adults with HIV-1 Infection at 96 Weeks: Subgroup Ana... by van Wyk, Jean A, Man, Choy Y, Sievers, Jörg, Urbaityte, Rimgaile, Underwood, Mark, Tenorio, Allan R, Pappa, Keith, Wynne, Brian, Smith, Kimberly, Gartland, Martin
Published 2019Text -
5
Abacavir Hypersensitivity Reaction Reporting Rates During a Decade of HLA‐B*5701 Screening as a Risk‐Mitigation Measure by Stainsby, Chris M., Perger, Teodora M., Vannappagari, Vani, Mounzer, Karam C., Hsu, Ricky K., Henegar, Cassidy E., Oyee, James, Urbaityte, Rimgaile, Lane, Charlotte E., Carter, Lindsay M., Pakes, Gary E., Shaefer, Mark S.
Published 2018Text -
6
1024. Impact of Treatment Adherence on Efficacy of DTG/3TC and DTG + TDF/FTC: Pooled Analysis of the GEMINI 1 and 2 Clinical Trials by Ait-Khaled, Mounir, Man, Choy, Sievers, Jorg, Grove, Richard, Wynne, Brian, Urbaityte, Rimgaile, van Wyk, Jean A, Madero, Juan G Sierra, Gulminetti, Roberto, Estrada, Vicente, Hagins, Debbie, Zolopa, Andrew, Tsai, Hung-Chin
Published 2020Text -
7
Three-year durable efficacy of dolutegravir plus lamivudine in antiretroviral therapy – naive adults with HIV-1 infection by Cahn, Pedro, Sierra Madero, Juan, Arribas, José R., Antinori, Andrea, Ortiz, Roberto, Clarke, Amanda E., Hung, Chien-Ching, Rockstroh, Jürgen K., Girard, Pierre-Marie, Sievers, Jörg, Man, Choy Y., Urbaityte, Rimgaile, Brandon, Daisy J., Underwood, Mark, Pappa, Keith A., Curtis, Lloyd, Smith, Kimberly Y., Gartland, Martin, Aboud, Michael, van Wyk, Jean, Wynne, Brian
Published 2022Text -
8
Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical T... by Cahn, Pedro, Madero, Juan Sierra, Arribas, José R., Antinori, Andrea, Ortiz, Roberto, Clarke, Amanda E., Hung, Chien-Ching, Rockstroh, Jürgen K., Girard, Pierre-Marie, Sievers, Jörg, Man, Choy Y., Urbaityte, Rimgaile, Brandon, Daisy J., Underwood, Mark, Tenorio, Allan R., Pappa, Keith A., Wynne, Brian, Gartland, Martin, Aboud, Michael, van Wyk, Jean, Smith, Kimberly Y.
Published 2020Text